Showing 51–61 of 61 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Country | WoS Quartile | CAS Division | Impact Factor | Scopus SJR | H-Index | Docs/yr | Self-Citation | Publisher | Profile |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Journal of the Egyptian National Cancer Institute ISSN: 1110-0362 / 2589-0409Diamond OA | 🇬🇧United Kingdom | Q3 | CAS Tier 4 | 2.2 | 0.551Q3 Diamond OA | — | 38 | 0% | SpringerOpen | Profile |
| 52 | Asia-Pacific Journal of Clinical Oncology ISSN: 1743-7555 / 1743-7563 | 🌐Australia | Q3 | CAS Tier 4 | 2.1 | 0.565Q2 | 23 | 118 | 0% | Wiley-Blackwell Publishing Ltd | Profile |
| 53 | Cancer Informatics ISSN: 1176-9351 | 🇬🇧United Kingdom | Q3 | CAS Tier 4 | 2.1 | 0.539Q3 | — | 18 | 4.2% | Libertas Academica | Profile |
| 54 | Cancer Journal ISSN: 1528-9117 / 1540-336X | 🇺🇸United States | Q3 | CAS Tier 4 | 2.1 | 0.869Q2 | 56 | 65 | 0% | Wolters Kluwer Health | Profile |
| 55 | Oncologie ISSN: 1292-3818 / 1765-2839 | 🇫🇷France | Q3 | CAS Tier 4 | 2.1 | 0.391Q3 | 9 | 44 | 7.1% | Tech Science Press | Profile |
| 56 | Translational Cancer Research ISSN: 2218-676X / 2219-6803 | 🇨🇳China | Q3 | CAS Tier 4 | 2.1 | 0.524Q2 | 22 | 519 | 6.7% | AME Publishing Company | Profile |
| 57 | International Journal of Breast Cancer ISSN: 2090-3170 / 2090-3189 | 🇬🇧United Kingdom | Q4 | CAS Tier 3 | 1.9 | 0.585Q3 | — | 12 | 0% | Hindawi Limited | Profile |
| 58 | Anticancer Research ISSN: 0250-7005 / 1791-7530 | 🌐Greece | Q4 | CAS Tier 4 | 1.8 | 0.58Q2 | 110 | 703 | 18.8% | International Institute of Anticancer Research | Profile |
| 59 | Cancer Biomarkers ISSN: 1574-0153 / 1875-8592 | 🇳🇱Netherlands | Q4 | CAS Tier 4 | 1.8 | 0.572Q2 | 33 | 121 | 0% | IOS Press | Profile |
| 60 | International Journal of Clinical and Experimental Pathology ISSN: 1936-2625 | 🇺🇸United States | Q4 | CAS Tier 4 | 1.3 | — | 43 | 130 | 0% | e-Century Publishing Corporation | Profile |
| 61 | Surgical Oncology Insight ISSN: 2950-2470 | 🌐International | Q4 | — | 1 | 0.381Q3 | — | — | N/A | ELSEVIER | Profile |